|
|
|
European Pharmaceutical Contractor
|
The DIA Euromeeting, held at the Palazzo dei Congressi in Rome, was attended by almost 2,000 delegates, speakers and exhibitors. Visitors came from 40 countries to take part in tutorials, technical tracks and a plenary session graced by Sir James Black - the doyen of drug discoverers and Nobel Prize winner. As ever, there was very strong representation from regulatory authorities - global, regional and national.
The theme of the meeting was 'e-ternal medical progress'. A large number of exhibitors demonstrated IT-related products and services and the e-R&D track updated the participants in the latest advances. We found it a challenge to choose which of the tracks to attend; however we felt that the balance between duration and content was perfect.
Plenary Session
Sir James Black gave the keynote speech in the plenary session. He gave an interesting history of drug discovery and development, dating the start of true medicinal research to William Perkin's attempt to synthesise quinine in 1856. Sir James also cited Paul Erlich and Paul Janssen as pioneers of modern drug research. He then discussed seven prerequisites for a drug development strategy. Five of these relate to the drug itself:
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Clinical Trial Logistics
22-23 May 2012, Marriott Regents Park, London, UK
SMi present their 6th annual Clinical Trial Logistics. Ts event continues a very successful and high quality series which integrates big Pharma and regulatory speakers to create a complete overview of the Clinical Trial Logistics field. This year’s event will address regulatory change, particularly for handling of temperature sensitive products, duties & taxes, planning a clinical trial, patient retention, label transactions, supply chain security, subcontractor selection & clinical trial logistics in emerging markets. This is achieved through a synthesis of case study presentations and topic analysis presenting by leading industry experts.
More info >> |
|
 |
News and Press Releases |
 |
Norwich Pharmaceuticals Announces Significant Business Growth
Norwich Pharmaceuticals, a provider of full-service contract development and manufacturing services for the pharmaceutical and biotech industry, announced today that the company has achieved significant business growth in first quarter, 2012 as compared to the same period in 2011. Key growth areas include volume of projects currently in development and commercial production, scope of projects expanded into multiple service categories, and total value of new business won.
More info >> |
|
|
